Extravasation Injuries in Adults
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Insertion of an intravascular catheter is one of the most common invasive procedures in hospitals worldwide. These intravascular lines are crucial in resuscitation, allow vital medication to be administered, and can be used to monitor the patients' real-time vital parameters. There is, however, growing recognition of potential risks to life and limb associated with their use. Medical literature is now replete with isolated case reports of complications succinctly described by Garden and Laussen (2004) as “An unending supply of “unusual” complications from central venous catheters.” This paper reviews complications of venous and arterial catheters and discusses treatment approaches and methods to prevent complications, based on current evidence and endeavours to provide information and guidance that will enable practitioners to prevent, recognise, and successfully treat extravasation injuries in adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Oncology patients are one of these populations, who due to chemotherapy, often present with veins that are fragile and hard to locate (Al-Benna et al., 2013).”
From Evaluation of a novel blood collection set for venipuncture in oncology patients with difficult venous access: Impact on sample quality, phlebotomist satisfaction and patient pain perception (2024) · cites this paper as Al-Benna et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Proceedings of the American Association for Cancer Research.
Konings, E. J. M., van den Brandt, P. A., Saris, W. H. M., Brants, H. A. M., & Goldbohm, R. A. (2001) · Cited by 764
Mucocutaneous reactions to chemotherapy
Susser, W. S., Whitaker-Worth, D. L., & Grant-Kels, J. M. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70488-3 · Cited by 294 · cited 1×
“The symptoms of the local reaction after extravasation are typically self limiting, most commonly without long-term sequelae [29].”
BackgroundExtravasation of systemic hemato-oncological therapies
Ener, R. A., Meglathery, S. B., & Styler, M. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh214 · Cited by 247 · cited 1×
“The addition of heparin either to flush solutions or to continuous infusions has not been shown to prolong peripheral catheter patency or to reduce the incidence of infiltration or extravasations conclusively and is not recommended [54].”
BackgroundGault, D. T. (1993) · British Journal of Plastic Surgery · doi:10.1016/0007-1226(93)90137-z · Cited by 230
Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease
Wang, J. J., Cortes, E., Sinks, L. F., & Holland, J. F. (1971) · Cancer · doi:10.1002/1097-0142(1971)28:4<837::aid-cncr2820280406>3.0.co;2-4 · Cited by 211 · cited 1×
“Two percent of the Medical Defence Union cases involving anaesthetic-related events between 1970–1982 (excluding deaths) were due to extravasation injuries [3], and for those patients who received a course of cytotoxic injections 5% experienced extravasations [4].”
BackgroundAdriamycin Activating a Recall Phenomenon After Radiation Therapy
DONALDSON, S. S., GLICK, J. M., & WILBUR, J. R. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-3-407 · Cited by 164 · cited 1×
“Patients who receive chemotherapy at the same site as radiotherapymay experience a reactivation of skin toxicity known as “recall” phenomenon [9, 14–17], and patients who have had an extravasation and receive further chemotherapy in a different site may experience an exacerbation of tissue damage in the original site.”
BackgroundTherapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs
Ignoffo, R. J., & Friedman, M. (1980) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(80)80023-5 · Cited by 158 · cited 1×
“This reduction in venous flow and risk of leakage at the intravenous site have been observed in patients with peripheral vascular disease [13, 18, 20, 24, 25] and in those with Raynaud’s phenomenon where arterial spasm may compromise the peripheral circulation [2, 19, 20].”
BackgroundExtravasation injuries on regional neonatal units: Figure 1
Wilkins, C. E., & Emmerson, A. J. B. (2004) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/adc.2003.028241 · Cited by 152 · cited 3×
“Treatment protocols for severe extravasations vary from conservative to aggressive management of the acute injury [28, 39, 41, 42], with additional variations in wound management [10, 43, 44].”
BackgroundPrevention and Management of Extravasation of Cytotoxic Drugs
Bertelli, G. (1995) · Drug Safety · doi:10.2165/00002018-199512040-00004 · Cited by 138 · cited 3×
“Hyaluronidase has been recommended for extravasation of vinca alkaloids [9].”
BackgroundEtiology and treatment of chemotherapeutic agent extravasation injuries: a review.
Rudolph, R., & Larson, D. L. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.7.1116 · Cited by 137 · cited 3×
“Agents that bind to DNA induce more damage than nonDNA-binding drugs [34, 35].”
BackgroundFederle, M. P., Chang, P. J., Confer, S. R., & Ozgun, B. (1998) · Radiology · doi:10.1148/radiology.206.3.9494479 · Cited by 137 · cited 3×
“Diabetic patients with peripheral neuropathy may not experience the pain of an infusate leaking into the subcutaneous tissues [2, 13, 19, 20], and those who suffer from superior vena cava syndrome have persistently elevated venous pressure which, again, may predispose to leakage at the intravenous site [5, 13].”
BackgroundVesicant Extravasation Part I: Mechanisms, Pathogenesis, and Nursing Care to Reduce Risk
Sauerland, C., Engelking, C., Wickham, R., & Corbi, D. (2006) · Oncology nursing forum · doi:10.1188/06.onf.1134-1141 · Cited by 129 · cited 3×
“Additionally, the significant free-radical formation of vesicant agents is suggested as a potential mechanism of the severe necrotic effect [35].”
BackgroundHyaluronidase as an antidote to extravasation ofVinca alkaloids: Clinical results
Bertelli, G., Dini, D., Forno, G. G., Gozza, A., Silvestro, S., Venturini, M., Rosso, R., & Pronzato, P. (1994) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01191807 · Cited by 122 · cited 1×
“Cold packs should not be administered in the event of extravasation of vinca alkaloids as increased tissue ulceration has been demonstrated in animal models with the use of cold packs [47].”
BackgroundSkin Necrosis From Extravasation of Intravenous Fluids in Children
Brown, A. S., Hoelzer, D. J., & Piercy, S. A. (1979) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-197908000-00002 · Cited by 115 · cited 5×
“Parenteral alimentation fluids, antibiotics, calcium, potassium, and sodium bicarbonate solutions also have the potential to cause severe tissue necrosis [10, 28].”
BackgroundInfluentialExtravasation: A Hazard of Intravenous Therapy
MacCara, M. E. (1983) · Annals of Pharmacotherapy · doi:10.1177/106002808301701002 · Cited by 102 · cited 2×
“1% and 6% in patients receiving chemotherapy [1].”
BackgroundManagement of extravasation injuries
Kumar, R. J., Pegg, S. P., & Kimble, R. M. (2001) · ANZ Journal of Surgery · doi:10.1046/j.1440-1622.2001.02104.x · Cited by 100 · cited 1×
“Objective staging of extravasations is useful for quality improvement purposes and for deciding the degree of intervention required [40].”
BackgroundEvaluation and Treatment of Chemotherapy Extravasation Injuries
Kassner, E. (2000) · Journal of Pediatric Oncology Nursing · doi:10.1053/jpon.2000.8063 · Cited by 97 · cited 1×
“Another more obvious risk is the one posed by intravenous drug users where vessels are often thrombosed and the number of accessible veins is limited, but those who require repeated infusions for their medical condition may experience the same difficulties [13, 21–23].”
BackgroundCurrent Thoughts on Extravasation Injuries
Heckler, F. R. (1989) · Clinics in Plastic Surgery · doi:10.1016/s0094-1298(20)31322-5 · Cited by 88
PITFALLS IN ANAESTHETIC PRACTICE
Utting, J. E. (1987) · British Journal of Anaesthesia · doi:10.1093/bja/59.7.877 · Cited by 81 · cited 1×
“Two percent of the Medical Defence Union cases involving anaesthetic-related events between 1970–1982 (excluding deaths) were due to extravasation injuries [3], and for those patients who received a course of cytotoxic injections 5% experienced extravasations [4].”
BackgroundAntitumor Agents: Extravasation, Management, and Surgical Treatment
Scuderi, N., & Onesti, M. G. (1994) · Annals of Plastic Surgery · doi:10.1097/00000637-199401000-00008 · Cited by 71
MANAGING COMPLICATIONS OF I.V. THERAPY
Millam, D. A. (1988) · Nursing · doi:10.1097/00152193-198803000-00020 · Cited by 70
Chest wall resection in the treatment of locally recurrent breast carcinoma
Faneyte, I. F., Rutgers, E. J. T., & Zoetmulder, F. A. �. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970901)80:5<865::aid-cncr6>3.0.co;2-k · Cited by 70
Heparin for prolonging peripheral intravenous catheter use in neonates
Shah, P. S., Ng, E., & Sinha, A. K. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002774.pub2 · Cited by 66 · cited 1×
“Regular inspection of the site and regulated delivery of intravenous fluids from continuous infusion pumps (usually limited to an hour at a time) may prevent the inadvertent infiltration of a large amount of fluid before detection, but it is helpful to remember that although occlusion alarms on infusion pumps may be s…”
BackgroundReversal of Dopamine Extravasation Injury with Topical Nitroglycerin Ointment
Denkler, K. A., Cohen, B. E., & Denkler, K. A. (1989) · Plastic and Reconstructive Surgery · doi:10.1097/00006534-198911000-00017 · Cited by 64 · cited 2×
“Hyaluronidase has been suggested to act via temporary breakdown of hyaluronic acid, which holds together tissue planes, and subsequent facilitation of drug dispersement and dilution [48].”
BackgroundRisk factors affecting infiltration of peripheral venous lines in infants
Phelps, S. J., & Helms, R. A. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80458-4 · Cited by 56 · cited 1×
“The pathophysiology of the interaction is not known, although free-radical scavenging and facilitation of elimination of drug from local tissues are postulated pathways of efficacy [49].”
BackgroundNafcillin Extravasation Injury: Use of Hyaluronidase as an Antidote
Zenk, K. E., Dungy, C. I., & Greene, G. R. (1981) · American journal of diseases of children · doi:10.1001/archpedi.1981.02130360021008 · Cited by 52 · cited 1×
“Treatment protocols for severe extravasations vary from conservative to aggressive management of the acute injury [28, 39, 41, 42], with additional variations in wound management [10, 43, 44].”
BackgroundHistologic changes induced in skin by extravasation of doxorubicin (adriamycin)
Bhawan, J., Petry, J., & Rybak, M. E. (1989) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.1989.tb00032.x · Cited by 50 · cited 1×
“Doxorubicin, for example, has been shown to remain in tissue for 5 months after extravasation [31] which means that the injury can present late with extensive tissue destruction [32].”
BackgroundPreventing the scars of neonatal intensive care.
Davies, J. M., Gault, D. T., & Buchdahl, R. (1994) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.70.1.f50 · Cited by 49 · cited 1×
“Some authors use the intraoperative fluorescent dye injection to detect the doxorubicin HCl in the tissue to ensure complete excision [52].”
BackgroundTreatment of metastatic colorectal carcinoma with 5-fluorouracil by mouth
Lahiri, S. R., Boileau, G., & Hall, T. C. (1971) · Cancer · doi:10.1002/1097-0142(1971)28:4<907::aid-cncr2820280414>3.0.co;2-9 · Cited by 46
Suppurative thrombophlebitis in children: a ten-year experience
KHAN, E. A., CORREA, A. G., & BAKER, C. J. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199701000-00014 · Cited by 45
Subhani, M., Sridhar, S., & DeCristofaro, J. D. (2001) · Journal of Perinatology · doi:10.1038/sj.jp.7200493 · Cited by 43 · cited 1×
“Infiltration of vasopressors such as dopamine and adrenaline produces intense local vasoconstriction and tissue ischaemia [10, 27], and in contrast, vasodilators may exacerbate the effects of extravasation by increasing local blood flow and enlarging the area of injury.”
BackgroundExtravasation Injury Associated with Low-Dose Dopamine
Chen, J. L., & O'Shea, M. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17184 · Cited by 43 · cited 2×
“Diabetic patients with peripheral neuropathy may not experience the pain of an infusate leaking into the subcutaneous tissues [2, 13, 19, 20], and those who suffer from superior vena cava syndrome have persistently elevated venous pressure which, again, may predispose to leakage at the intravenous site [5, 13].”
BackgroundShapiro, J., & Richardson, G. E. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.10.2237 · Cited by 43 · cited 2×
“Repeated infusion of the offending agent, even in another limb, may induce a recall reaction at the site of extravasation [14].”
BackgroundAcute Management of Dopamine Infiltration Injury with Regitine
Siwy, B. K., & Sadove, A. M. (1987) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-198710000-00024 · Cited by 40 · cited 3×
“Treatment protocols for severe extravasations vary from conservative to aggressive management of the acute injury [28, 39, 41, 42], with additional variations in wound management [10, 43, 44].”
BackgroundCase report: topical DMSO for mitomycin-C-induced skin ulceration.
Alberts, D. S., & Dorr, R. T. (1991) · PubMed · Cited by 39
Zimmet, S. E. (1993) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1993.tb00404.x · Cited by 37 · cited 2×
“Hypertonic solutions which contain ions and are also acidic are particularly damaging to tissues because they are capable of killing cells by precipitating cell proteins [36].”
BackgroundExtravasation injury to the hand by intravenous phenytoin: Report of three cases
Rao, V. K., Feldman, P. D., & Dibbell, D. G. (1988) · Journal of neurosurgery · doi:10.3171/jns.1988.68.6.0967 · Cited by 37 · cited 1×
“The pH of a substance outside of the physiological range may have an adverse effect on tissue [2, 18, 37, 38].”
BackgroundMode of chemotherapy does not affect complications with an implantable venous access device
Brown, D. F., Muirhead, M. J., Travis, P. M., Vire, S. R., Weller, J., & Hauer‐Jensen, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970901)80:5<966::aid-cncr20>3.0.co;2-t · Cited by 36 · cited 1×
“Another more obvious risk is the one posed by intravenous drug users where vessels are often thrombosed and the number of accessible veins is limited, but those who require repeated infusions for their medical condition may experience the same difficulties [13, 21–23].”
BackgroundSoft-tissue Reconstruction Following Extravasation of Chemotherapeutic Agents
Shenaq, S. M., Abbase, E.-H. A., & Friedman, J. D. (1996) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30355-7 · Cited by 34 · cited 7×
“, carcinoma) and morphofunctional damage [13, 45, 46].”
BackgroundInfluentialBerghammer, P., Pöhnl, R., Baur, M., & Dittrich, C. (2001) · Supportive Care in Cancer · doi:10.1007/s005200000182 · Cited by 34 · cited 1×
“Early local symptoms of a vesicant extravasation resemble those of an irritant extravasation: local pain, erythema, burning, pruritus, or swelling [33, 34].”
BackgroundLIMITING THE DAMAGE OF IATROGENIC EXTRAVASATION INJURY IN NEONATES
Harris, P. A., Bradley, S., & Moss, A. L. H. (2001) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-200103000-00053 · Cited by 29
An unending supply of ‘unusual’ complications from central venous catheters
Garden, A. L., & Laussen, P. C. (2004) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2004.01439.x · Cited by 27 · cited 4×
“Peripheral rather than central venous administration of antineoplastic agents is more likely to be associated with frequent cannulation which is a risk factor for extravasation, and this should be avoided [5, 7].”
BackgroundInfluentialTreatment of Extravasation from Parenteral Nutrition Solution
Gil, M.-E., & Mateu, J. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.16487 · Cited by 27 · cited 4×
“Patients who have undergone radical mastectomy, axillary surgery, or lymph node dissection may have impaired circulation in a particular limb which reduces venous flow and may allow intravenous solutions to pool and leak out [18].”
BackgroundInfluentialSkin necrosis from intravenously infused materials.
Dufresne, R. G. (1987) · PubMed · Cited by 25
Skin Cancer Occurring 10 Years after the Extravasation of Doxorubicin
Lauvin, R., Miglianico, L., & Hellegouarc'h, R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503163321117 · Cited by 23 · cited 3×
“One case of squamous cell carcinoma of the skin was documented at the site of a doxorubicin extravasation 10 years previously [50].”
BackgroundInfluentialDose-dependent skin ulcers in mice treated with DNA binding antitumor antibiotics
Soble, M. J., Dorr, R. T., Plezia, P. M., & Breckenridge, S. (1987) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00252956 · Cited by 23
Falcone, P. A., Barrall, D. T., Jeyarajah, D. R., & Grossman, J. A. I. (1989) · Annals of Plastic Surgery · doi:10.1097/00000637-198902000-00010 · Cited by 21 · cited 1×
“Treatment protocols for severe extravasations vary from conservative to aggressive management of the acute injury [28, 39, 41, 42], with additional variations in wound management [10, 43, 44].”
BackgroundDaunomycin, Adriamycin, and Recall Effect
Baer, D. M., & WILKINSON, L. S. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-2-259_3 · Cited by 15 · cited 1×
“Patients who receive chemotherapy at the same site as radiotherapymay experience a reactivation of skin toxicity known as “recall” phenomenon [9, 14–17], and patients who have had an extravasation and receive further chemotherapy in a different site may experience an exacerbation of tissue damage in the original site.”
BackgroundEye on Elders: CE Credit: IV Vesicants: How to Avoid Extravasation
Wood, L. S., & Gullo, S. M. (1993) · AJN American Journal of Nursing · doi:10.1097/00000446-199304000-00020 · Cited by 14 · cited 1×
“chemotherapy for cancer are often fragile, mobile, and difficult to cannulate [12, 13].”
BackgroundPlastic Surgical Problems in the Neonatal Intensive Care Unit
Friedman, J. D. (1998) · Clinics in Plastic Surgery · doi:10.1016/s0094-1298(20)32452-4 · Cited by 13 · cited 1×
“Treatment protocols for severe extravasations vary from conservative to aggressive management of the acute injury [28, 39, 41, 42], with additional variations in wound management [10, 43, 44].”
BackgroundHyaluronidase-injectable microparticles intended for the treatment of extravasation
Modena, T., Conti, B., Genta, I., Pauanetto, F., Tira, M. E., Sini, P., & Gazzaniga, A. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006838 · Cited by 9 · cited 1×
“This reduction in venous flow and risk of leakage at the intravenous site have been observed in patients with peripheral vascular disease [13, 18, 20, 24, 25] and in those with Raynaud’s phenomenon where arterial spasm may compromise the peripheral circulation [2, 19, 20].”
BackgroundCABG Surgery: The Second Time Around
Beattie, S. (1993) · AJN American Journal of Nursing · doi:10.2307/3464246 · Cited by 1
Research works printed but not linked: 4
- Gault D Challands J Kaufman L Ginsburg R Extravasation of Drugs Anaesthesia Review 1997 13 Edinburgh, UK Churchill Livingstone
- Smith R Prevention and treatment of extravasation British Journal of Parenteral Therapy 1985 6 5 114 118 2-s2.0-0021825047
- Brown AS Hoelzer DJ Piercy SA Skin necrosis from extravasation of intravenous fluids in children Plastic and Reconstructive Surgery 1979 64 2 145 150 2-s2.0-0018385505 109874 · DOI
- Kerrison T Woodhull J Reducing the risk of thrombophebitis: comparison of Teflon and Vialon cannulae Professional Nurse London 1994 9 662 662
Cited by
Overview, prevention and management of chemotherapy extravasation
Kreidieh, F. Y. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i1.87 · Cited by 197
Aberegg, S. K. (2015) · CHEST Journal · doi:10.1016/j.chest.2015.12.001 · Cited by 117
Oncologic Emergencies: Recognition and Initial Management.
Higdon, M. L., Atkinson, C. J., & Lawrence, K. V. (2018) · PubMed · Cited by 91
Extravasation of Noncytotoxic Drugs
David, V., Christou, N., Etienne, P., Almeida, M., Roux, A., Taïbi, A., & Mathonnet, M. (2020) · Annals of Pharmacotherapy · doi:10.1177/1060028020903406 · Cited by 47
Pagnutti, L., Bin, A., Donato, R., Lena, G. D., Fabbro, C. M., Fornasiero, L., Gerratana, A., Rigon, L., Gonella, S., & Palese, A. (2015) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2015.06.008 · Cited by 50
Metadata
- Authors
- Al-Benna, S., O’Boyle, C., & Holley, J.
- Affiliations
- Department of Burns and Plastic Surgery, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK
- Nottingham City Hospital (GB)
- Venue
- ISRN Dermatology
- Publisher
- Wiley
- Published
- 2013-05-08
- Volume
- 2013
- Pages
- 1-8
- ISSN
- 2090-4592 (ISSN-L)
- 2090-4606
- PMC
- PMC3664495
- OpenAlex
- W2058374688
- Semantic Scholar
- 39d96ec5b29dc65ba16035160df1b9de0399aa3f
- Cited by
- 121
- References
- 51
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 11 · 2023: 11 · 2022: 17 · 2021: 13 · 2020: 12 · 2019: 15 · 2018: 8 · 2017: 9 · 2016: 7 · 2015: 5 · 2014: 4
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- ISRN Dermatology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Central Venous Catheters and Hemodialysis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vascular Procedures and Complications
- Health Sciences › Medicine › Dermatology › Chemotherapy-related skin toxicity
- Keywords
- extravasation injury, intravascular catheters, central venous catheters, arterial catheters, catheter-related complications, complication prevention, adults
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.